New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH Registry)

American Journal of Cardiology

Volumn 112, Issue 9, 2013, Pages 1390-1395

  Parashar, Susmita ^a   Kella, Danesh ^a   Reid, Kimberly J ^b   Spertus, John A ^b   Tang, Fengming ^b   Langberg, Jonathan ^a   Vaccarino, Viola ^a,c   Kontos, Michael C ^d   Lopes, Renato D ^e   Lloyd, Michael S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTICOAGULANT AGENT; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; FIBRINOLYTIC AGENT; HIGH SENSITIVITY C REACTIVE PROTEIN; TROPONIN T; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CONFIDENCE INTERVALS; DIAGNOSTIC TESTS, ROUTINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT ADMISSION; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; UNITED STATES;

EID: 84886929145     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.07.006     Document Type: Article

References (28)

1. S. Acikel, M. Sari, and R. Akdemir The relationship between acute coronary syndrome and inflammation: a case of acute myocardial infarction associated with coronary involvement of Sweet's syndrome Blood Coagul Fibrinolysis 21 2010 703 706
2. K. Kruszewski, A.E. Scott, J.L. Barclay, G.R. Small, B.L. Croal, J.E. Moller, J.K. Oh, and G.S. Hillis Noninvasive assessment of left ventricular filling pressure after acute myocardial infarction: a prospective study of the relative prognostic utility of clinical assessment, echocardiography, and B-type natriuretic peptide Am Heart J 159 2010 47 54
3. P. Damman, M.A. Beijk, W.J. Kuijt, N.J. Verouden, N. van Geloven, J.P. Henriques, J. Baan, M.M. Vis, M. Meuwissen, J.P. van Straalen, J. Fischer, K.T. Koch, J.J. Piek, J.G. Tijssen, and R.J. de Winter Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction J Am Coll Cardiol 57 2011 29 36
4. J.A. de Lemos, D.A. Morrow, J.H. Bentley, T. Omland, M.S. Sabatine, C.H. McCabe, C. Hall, C.P. Cannon, and E. Braunwald The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014 1021
5. S. Behar, D. Tanne, M. Zion, H. Reicherreiss, E. Kaplinsky, A. Caspi, A. Palant, and U. Goldbourt Incidence and prognostic significance of chronic atrial fibrillation among 5,839 consecutive patients with acute myocardial infarction. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial Am J Cardiol 70 1992 816 818
6. J.E. Madias, D.C. Patel, and D. Singh Atrial fibrillation in acute myocardial infarction: a prospective study based on data from a consecutive series of patients admitted to the coronary care unit Clin Cardiol 19 1996 180 186
7. F.E. Nielsen, H.T. Sorensen, J.H. Christensen, L. Ravn, and S.E. Rasmussen Reduced occurrence of atrial fibrillation in acute myocardial infarction treated with streptokinase Eur Heart J 12 1991 1081 1083
8. A.C. Salisbury, K.P. Alexander, K.J. Reid, F.A. Masoudi, S.S. Rathore, T.Y. Wang, R.G. Bach, S.P. Marso, J.A. Spertus, and M. Kosiborod Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction Circ Cardiovasc Qual Outcomes 3 2012 337 346
9. S.V. Arnold, P.S. Chan, P.G. Jones, C. Decker, D.M. Buchanan, H.M. Krumholz, P.M. Ho, J.A. Spertus, and Cardiovasc Outcomes Res C Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry Circ Cardiovasc Qual Outcomes 4 2011 467 476
10. R version 2.1.1 (R Development Core Team) (2006) R: A Language and Environment for Statistical Computing 2006 R Foundation for Statistical Computing Vienna, Austria
11. D.M. Lloyd-Jones, T.J. Wang, E.P. Leip, M.G. Larson, D. Levy, R.S. Vasan, R.B. D'Agostino, J.M. Massaro, A. Beiser, P.A. Wolf, and E.J. Benjamin Lifetime risk for development of atrial fibrillation: the Framingham Heart Study Circulation 110 2004 1042 1046
12. K.K. Patton, P.T. Ellinor, S.R. Heckbert, R.H. Christenson, C. DeFilippi, J.S. Gottdiener, and R.A. Kronmal N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study Circulation 120 2009 1768 1774
13. R.B. Schnabel, M.G. Larson, J.F. Yamamoto, S. Kathiresan, J. Rong, D. Levy, J.F. Keaney Jr., T.J. Wang, R.S. Vasan, and E.J. Benjamin Relation of multiple inflammatory biomarkers to incident atrial fibrillation Am J Cardiol 104 2009 92 96
14. R.B. Schnabel, M.G. Larson, J.F. Yamamoto, L.M. Sullivan, M.J. Pencina, J.B. Meigs, G.H. Tofler, J. Selhub, P.F. Jacques, P.A. Wolf, J.W. Magnani, P.T. Ellinor, T.J. Wang, D. Levy, R.S. Vasan, and E.J. Benjamin Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community Circulation 121 2010 200 207
15. A. Rossi, M. Enriquez-Sarano, J.C. Burnett Jr., A. Lerman, M.D. Abel, and J.B. Seward Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study J Am Coll Cardiol 35 2000 1256 1262
16. B.S. Crenshaw, S.R. Ward, C.B. Granger, A.L. Stebbins, E.J. Topol, and R.M. Califf Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries J Am Coll Cardiol 30 1997 406 413
17. K. Kinjo, H. Sato, Y. Ohnishi, E. Hishida, D. Nakatani, H. Mizuno, M. Fukunani, Y. Koretsune, H. Takeda, M. Hori, and Osaka Acute Coronary I Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention Am J Cardiol 92 2003 1150 1154
18. L. Kober, K. Swedberg, J.J.V. McMurray, M.A. Pfeffer, E.J. Velazquez, R. Diaz, A.P. Maggioni, V. Mareev, G. Opolski, F. Van de Werf, F. Zannad, G. Ertl, S.D. Solomon, S. Zelenkofske, J.L. Rouleau, J.D. Leimberger, and R.M. Califf Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction Eur J Heart Fail 8 2006 591 598
19. S.S. Rathore, A.K. Berger, K.P. Weinfurt, K.A. Schulman, W.J. Oetgen, B.J. Gersh, and A.J. Solomon Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes Circulation 101 2000 969 974
20. M.M. Asanin, S.S. Stankovic, I. Mrdovic, D.D. Matic, L.L. Savic, N.N. Majkic-Singh, M. Ostojic, and Z. Vasiljevic B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention Peptides 35 2012 74 77
21. G. Laurent, G. Dentan, D. Moreau, M. Zeller, Y. Laurent, M. Vincent-Martin, I. Lhuillier, H. Makki, J.E. Wolf, and Y. Cottin Atrial fibrillation during myocardial infarction with and without ST segment elevation Arch Mal Coeur Vaiss 98 2005 608 614
22. M.K. Chung, D.O. Martin, D. Sprecher, O. Wazni, A. Kanderian, C.A. Carnes, J.A. Bauer, P.J. Tchou, M.J. Niebauer, A. Natale, and D.R. Van Wagoner C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 2001 2886 2891
23. T. Yoshizaki, K. Umetani, Y. Ino, N. Takahashi, M. Nakamura, T. Seto, and K. Aizawa Activated inflammation is related to the incidence of atrial fibrillation in patients with acute myocardial infarction Intern Med (Japan) 51 2012 12
24. D. Aronson, M. Boulos, A. Suleiman, S. Bidoosi, Y. Agmon, M. Kapeliovich, R. Beyar, W. Markiewicz, H. Hammerman, and M. Suleiman Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction Am J Cardiol 100 2007 755 759
25. O. Gedikli, C. Orem, M. Baykan, C. Karahan, M. Kucukosmanoglu, S. Sahin, L. Korkmaz, H. Yilmaz, and S. Celik Association between serum C-reactive protein elevation and atrial fibrillation after first anterior myocardial infarction Clin Cardiol 31 2008 482 487
26. J. Schmitt, G. Duray, B.J. Gersh, and S.H. Hohnloser Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications Eur Heart J 30 2009 1038 1045
27. K.R. Nilsson Jr., S.M. Al-Khatib, Y. Zhou, K. Pieper, H.D. White, A.P. Maggioni, L. Kober, C.B. Granger, E.F. Lewis, J.J. McMurray, R.M. Califf, and E.J. Velazquez Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial Heart 96 2010 838 842
28. C.K. Wong, H.D. White, R.G. Wilcox, D.A. Criger, R.M. Califf, E.J. Topol, and E.M. Ohman Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries Heart 88 2002 357 362